MOGS. FOGSI
High risk obstetrics , cancer screening
Training in
1.Hysterolaproscopy at FOGSI Certified
2.Basic ultrasonography at
FOGSI recognized centre
3. Basic training in reproductive medicine at FOGSI recognized centre
Research:
Currently part of RSV MAT 009- A Phase III, randomized, double -blind, placebo-controlled multi-country study to demonstrate efficacy of a single dose of unadjuvanted RSV Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated LRTI in their infants up to 6 months of age
MOGS. FOGSI
High risk obstetrics , cancer screening
Training in
1.Hysterolaproscopy at FOGSI Certified
2.Basic ultrasonography at
FOGSI recognized centre
3. Basic training in reproductive medicine at FOGSI recognized centre
Research:
Currently part of RSV MAT 009- A Phase III, randomized, double -blind, placebo-controlled multi-country study to demonstrate efficacy of a single dose of unadjuvanted RSV Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated LRTI in their infants up to 6 months of age